Received final 510(k) clearance for Integrity™ Implant System, a regenerative hyaluronic acid-based patch system for augmentation of rotator cuff repairs

Completed enrollment in Hyalofast® pivotal Phase III clinical study, a key milestone in its path to achieving US FDA approval

Tactoset® received additional FDA 510(k) clearance to be combined with autogenous bone marrow aspirate (BMA)

First surgeries were performed using the new RevoMotion™ Reverse Shoulder Arthroplasty System and limited market release was initiated

Commenced full market release of X-Twist™ Fixation System, a cornerstone product in Anika’s Sports Medicine portfolio

To Top